Literature DB >> 11813875

Diabetic nephropathy: the central role of renal proximal tubular cells in tubulointerstitial injury.

A O Phillips1, R Steadman.   

Abstract

Diabetic nephropathy is now the commonest cause of end stage renal disease and accounts for 30-40% of all patients requiring renal replacement therapy. Furthermore, the incidence of diabetic nephropathy continues to increase, in part due to the improved survival of type 2 diabetic patients as the cardiovascular mortality in this group declines (Ritz and Stefanski, 1996). Clinically incipient nephropathy is first manifest by the onset of persistent microalbuminuria, after which, overt diabetic nephropathy is heralded by the appearance of persistent proteinuria. Subsequently, there is a progressive decline in glomerular filtration rate (GFR) resulting, within 5 years, in end stage renal disease in 50% of patients (Hasslacher et al., 1989). The pathology of the renal lesions are similar in type I and II diabetes (Taft et al., 1994), although it has been suggested that there is more heterogeneity in type II diabetes (Chihara et al., 1986). Studies analysing structural-functional relationships have demonstrated that the development of proteinuria correlates with the degree of mesangial expansion (Mauer et al., 1984; White and Bilous, 2000). Although diabetic nephropathy was traditionally considered a primarily glomerular disease, it is now widely accepted that the rate of deterioration of function correlates best with the degree of renal tubulointerstitial fibrosis (Mauer et al., 1984, Bohle et al., 1991). This suggests that although in the majority of patients the primary event is a condition manifest by glomerular changes resulting in proteinuria, the long-term outcome is determined by events in the renal interstitium. With the increasing awareness of the importance of these pathological interstitial changes, interest has focused on the role of cells, such as the epithelial cells of the proximal tubule (PTC) or the interstitial myofibroblast, in the initiation of fibrosis. The aim of the present review is to analyse the available data supporting the role for the PTC in orchestrating renal interstitial fibrosis in diabetic nephropathy as a result of glucose-dependent alterations in PTC function. The potential for subsequent effects on PTC-fibroblast cross-talk will also be considered.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11813875     DOI: 10.14670/HH-17.247

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  60 in total

1.  Potent activation of multiple signalling pathways by C-peptide in opossum kidney proximal tubular cells.

Authors:  N M Al-Rasheed; F Meakin; E L Royal; A J Lewington; J Brown; G B Willars; N J Brunskill
Journal:  Diabetologia       Date:  2004-05-26       Impact factor: 10.122

2.  High glucose-induced thioredoxin-interacting protein in renal proximal tubule cells is independent of transforming growth factor-beta1.

Authors:  Weier Qi; Xinming Chen; Richard E Gilbert; Yuan Zhang; Mark Waltham; Maria Schache; Darren J Kelly; Carol A Pollock
Journal:  Am J Pathol       Date:  2007-08-03       Impact factor: 4.307

3.  Urinary monocyte chemoattractant protein-1 and hepcidin and early diabetic nephropathy lesions in type 1 diabetes mellitus.

Authors:  Gudeta D Fufaa; E Jennifer Weil; Robert G Nelson; Robert L Hanson; William C Knowler; Brad H Rovin; Haifeng Wu; Jon B Klein; Theodore E Mifflin; Harold I Feldman; Ramachandran S Vasan; Paul L Kimmel; John W Kusek; Michael Mauer
Journal:  Nephrol Dial Transplant       Date:  2015-02-03       Impact factor: 5.992

4.  Implication of dysregulation of the canonical wingless-type MMTV integration site (WNT) pathway in diabetic nephropathy.

Authors:  T Zhou; X He; R Cheng; B Zhang; R R Zhang; Y Chen; Y Takahashi; A R Murray; K Lee; G Gao; J-X Ma
Journal:  Diabetologia       Date:  2011-10-21       Impact factor: 10.122

5.  Role of protein kinase C in advanced glycation end products-induced epithelial-mesenchymal transition in renal proximal tubular epithelial cells.

Authors:  Shuwang Ge; Rui Zeng; Yun Luo; Lin Liu; Honglan Wei; Juan Zhang; Huan Zhou; Gang Xu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-06-10

6.  Urinary cystatin C as a potential risk marker for cardiovascular disease and chronic kidney disease in patients with obesity and metabolic syndrome.

Authors:  Noriko Satoh-Asahara; Takayoshi Suganami; Takafumi Majima; Kazuhiko Kotani; Yasuhisa Kato; Rika Araki; Kazunori Koyama; Taiichiro Okajima; Makito Tanabe; Mariko Oishi; Akihiro Himeno; Shigeo Kono; Akira Sugawara; Masakazu Hattori; Yoshihiro Ogawa; Akira Shimatsu
Journal:  Clin J Am Soc Nephrol       Date:  2010-11-04       Impact factor: 8.237

Review 7.  Role of Kidney Biopsies for Biomarker Discovery in Diabetic Kidney Disease.

Authors:  Helen C Looker; Michael Mauer; Robert G Nelson
Journal:  Adv Chronic Kidney Dis       Date:  2018-03       Impact factor: 3.620

8.  Tuberin inhibits production of the matrix protein fibronectin in diabetes.

Authors:  Samy L Habib; Mukesh Yadav; Shaza Tizani; Basant Bhandari; Anthony J Valente
Journal:  J Am Soc Nephrol       Date:  2012-08-16       Impact factor: 10.121

Review 9.  Can we target tubular damage to prevent renal function decline in diabetes?

Authors:  Joseph V Bonventre
Journal:  Semin Nephrol       Date:  2012-09       Impact factor: 5.299

Review 10.  The tubular hypothesis of nephron filtration and diabetic kidney disease.

Authors:  Volker Vallon; Scott C Thomson
Journal:  Nat Rev Nephrol       Date:  2020-03-09       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.